Joanna Ghobrial, MD
Cardiovascular Disease · Los Angeles, CANPI 1720253149
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 45.5% of the total. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $530.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$43K
- Medtronic$37K
- Edwards Lifesciences$14K
- Abbott$249
- Merck$139
- Boston Scientific$103
- plus $151 from 4 others
Across 13 payments — averaging $14,765 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$190K
- Masimo Corporation$2K
What the payments were for
- Consulting fees$51,56255%
- Speaking & faculty fees$25,71427%
- Travel & lodging$12,39513%
- Food & beverage$4,7875%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 38 | $42,983 |
| Medtronic(2 entities) | 90 | $37,222 |
| Edwards Lifesciences | 33 | $13,610 |
| Abbott | 2 | $249 |
| Merck | 8 | $139 |
| Boston Scientific | 3 | $103 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $69 |
| Angiodynamics, Inc. | 1 | $40 |
| Abiomed | 1 | $24 |
| CSL Behring | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$41,253
- GORE CARDIOFORM ASD Occluder$40,615
- HARMONY$26,829
- Edwards SAPIEN 3 Transcatheter Heart Valve$11,884
- MELODY TPV$563
- CoreValve Evolut$204
- PORTICO$135
- DRAGONFLY OPSTAR$114
How this compares
$94,458 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $41,561 |
| XareltoRivaroxaban | 14 | $11,982 |
| ClopidogrelClopidogrel Bisulfate | 23 | $556 |
| Torsemide | 37 | $491 |
| Metoprolol Succinate | 29 | $280 |
| Spironolactone | 21 | $242 |
| Atorvastatin Calcium | 20 | $175 |
| Furosemide | 14 | $143 |
| Losartan Potassium | 11 | $111 |
| Carvedilol | 14 | $93 |
| Amlodipine Besylate | 19 | $76 |
| Metoprolol Tartrate | 19 | $75 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Los Angeles
- Cathleen Bairey-MerzLos Angeles$1.2M
- Karol WatsonLos Angeles$553K
- Jamil AboulhosnLos Angeles$423K
- Darren BermanLos Angeles$392K
- Arash NayeriLos Angeles$281K
- Gregg FonarowLos Angeles$260K
- Martha GulatiLos Angeles$141K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.